Entering text into the input field will update the search result below

OncoSec Medical reports FQ4 and FY15 results

  • OncoSec Medical (NASDAQ:ONCS +0.2%) FQ4 results: Revenues: $0; R&D Expense: $3.8M (+100.0%); SG&A: $2.7M (+58.8%); Net Loss: ($6.5M) (-80.6%); Loss Per Share: ($0.48) (-60.0%).
  • FY2015 results: Revenues: $0; R&D Expense: $13.1M (+125.9%); SG&A: $8.1M (+30.6%); Net Loss: ($21.2M) (-76.7%); Loss Per Share: ($1.67) (-32.5%); Quick Assets: $32M (-15.6%).
  • No guidance given.

Recommended For You

More Trending News

About ONCSQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ONCSQ--
OncoSec Medical Incorporated